Olanzapine plus fluoxetine: Phase III; Under FDA review

In an 8-week, double-blind, placebo-controlled U.S. Phase III trial in 833 patients, the estimated median time to a partial response for OFC patients

Read the full 235 word article

How to gain access

Continue reading with a
two-week free trial.